Risk of Peritoneal Cancer After Risk-Reducing Bilateral Salpingo-Oophorectomy for Women With Germline BRCA Pathogenic Variants: A Cause for Concern or Potentially Avoidable?

J Clin Oncol. 2022 Jun 10;40(17):1850-1852. doi: 10.1200/JCO.22.00325. Epub 2022 Mar 25.

Authors

Kelly-Anne Phillips^{1

2}, Michael L Friedlander^{3

4}

Affiliations

¹ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
² Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
³ Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
⁴ Prince of Wales Clinical School, University of New South Wales Medicine, Sydney, New South Wales, Australia.

PMID: 35333598
DOI: 10.1200/JCO.22.00325

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

BRCA1 Protein / genetics
BRCA2 Protein / genetics
Breast Neoplasms* / genetics
Breast Neoplasms* / surgery
Female
Genes, BRCA1
Genes, BRCA2
Germ Cells / pathology
Humans
Mutation
Ovarian Neoplasms* / genetics
Ovarian Neoplasms* / pathology
Ovarian Neoplasms* / surgery
Ovariectomy
Peritoneal Neoplasms* / genetics
Peritoneal Neoplasms* / prevention & control
Salpingo-oophorectomy

Substances

BRCA1 Protein
BRCA2 Protein